IP Library Granted Patent US 8,771,955
Granted Patent B2
US 8,771,955 · App. 13/435,440 · Granted Jul 8, 2014

Device and method for extraction and analysis of nucleic acids from biological samples

Inventors: Michael W. Reed (Lake Forest Park, WA); Oliver Z. Nanassy (Edmonds, WA)
Assignee: Blood Cell Storage, Inc.
C12Q1/6851C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,955
App. No.
13/435,440
Granted
Jul 8, 2014
Kind
B2
Abstract

Device and methods for extracting and analyzing nucleic acids from biological samples.

Claims (20)

1. A method for quantifying and amplifying the amount of nucleic acids in a sample, comprising:

(a) contacting nucleic acids from a sample with a nucleic acid amplification reaction mixture comprising a first fluorescent compound having a first fluorescence emission maximum, a second fluorescent compound having a second fluorescence emission maximum, and a third fluorescent compound having a third fluorescence emission maximum and a fluorescence intensity dependent on the concentration of amplified nucleic acids, wherein the first, second, and third fluorescence emission maxima are different, each having a fluorescence intensity dependent on the concentration of nucleic acids;

(b) measuring the fluorescence of the first fluorescent compound to determine the amount of nucleic acids;

(c) treating the nucleic acids and the nucleic acid amplification reaction mixture under conditions for amplifying the nucleic acids to provide amplified nucleic acids; and

(d) measuring the fluorescence of the first fluorescent compound to determine the amount of amplified nucleic acids.

2. The method of claim 1 , wherein the first fluorescent compound is a minor groove binder or an intercalating agent.

3. The method of claim 1 further comprising measuring the fluorescence of the second fluorescent compound to determine the presence of a gene or gene product.

4. The method of claim 1 , wherein the second fluorescent compound is an oligonucleotide probe.

5. The method of claim 1 further comprising measuring the fluorescence of the third fluorescent compound to determine the presence of a gene or gene product.

6. The method of claim 1 wherein the third fluorescent compound is an oligonucleotide probe.

7. A method for quantifying and amplifying the amount of nucleic acids in a sample, comprising:

(a) contacting nucleic acids from a sample with a first fluorescent compound having a first fluorescence emission maximum and a fluorescence intensity dependent on the concentration of nucleic acids;

(b) measuring the fluorescence of the first fluorescent compound to determine the amount of nucleic acids;

(c) treating the nucleic acids with a nucleic acid amplification reaction mixture under conditions for amplifying the nucleic acids to provide amplified nucleic acids, wherein the nucleic acid amplification reaction mixture comprises a second fluorescent compound having a second fluorescence emission maximum and a fluorescence intensity dependent on the concentration of nucleic acids, and a third fluorescent compound having a third fluorescence emission maximum and a fluorescence intensity dependent on the concentration of nucleic acids, wherein the first, second, and third fluorescence emission maxima are different; and

(d) measuring the fluorescence of the second fluorescent compound to determine the presence of a gene or gene product.

8. The method of claim 7 further comprising measuring the fluorescence of the first fluorescent compound to determine the amount of amplified nucleic acids.

9. The method of claim 7 , wherein the first fluorescent compound is a minor groove binder or an intercalating agent.

10. The method of claim 7 , wherein the second fluorescent compound is an oligonucleotide probe.

11. The method of claim 7 , wherein the third fluorescent compound is an oligonucleotide probe.

12. The method of claim 7 further comprising measuring the fluorescence of the third fluorescent compound to determine the presence of a gene or gene product.

Assignments (2)
SECURITY INTEREST Recorded May 30, 2014
From: BLOOD CELL STORAGE, INC.
To: DOUGLAS A. BEVIS, IN HIS CAPACITY AS COLLATERAL AGENT
Reel/Frame 033062/0390 →
SECURITY INTEREST Recorded Mar 12, 2014
From: BLOOD CELL STORAGE, INC.
To: BEVIS, IN HIS CAPACITY AS COLLATERAL AGENT, DOUGLAS A.
Reel/Frame 032418/0372 →
Continuity (5)
Continuation 12605925 · Oct 26, 2009
Division 11768076 · Jun 25, 2007
Provisional Application 60816577 · Jun 26, 2006
Provisional Application 60910609 · Apr 6, 2007
Related Publication 20120252017A1 · Oct 4, 2012